Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma

<p>Abstract</p> <p>Background</p> <p>The <it>enhancer of zeste homolog 2 </it>(<it>EZH2</it>) gene exerts oncogene-like activities and its (over)expression has been linked to several human malignancies. Here, we studied a possible association bet...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Pfitzenmaier Jesco, Schirmacher Peter, Hoppe-Seyler Karin, Hüsing Johannes, Pritsch Maria, Macher-Goeppinger Stephan, Wagener Nina, Haferkamp Axel, Hoppe-Seyler Felix, Hohenfellner Markus
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMC 2010-10-01
Saila:BMC Cancer
Sarrera elektronikoa:http://www.biomedcentral.com/1471-2407/10/524
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak